Table 1. Characteristics of training samples.
| Accession No.a | Sample No. | Cell type | Dose (Gy) | Time after radiation (h) |
|---|---|---|---|---|
| GSE26835 | 362 | Lymphoblast | 10.0 | 6 |
| GSE36720b | 9 | LNCap, PC3, DU145 | 10.0 | 6 |
| GSE8917 | 5 | Peripheral blood | 8.0 | 6 |
| GSE35372 | 6 | HL60, RV+ | 8.0 | 4 |
| GSE30043 | 3 | U87 | 8.5 | 4 |
| GSE23515c | 12 | Peripheral blood | 2.0 | 6 |
| GSE25772 | 4 | Fibroblast | 2.0 | 8 |
| GSE30044d | 3 | HEK | 2.0 | 4 |
| GSE8917 | 5 | Peripheral blood | 2.0 | 6 |
| GSE6971 | 4 | Fibroblast | 1.5 | 6 |
| GSE7075 | 6 | Fibroblast | 1.5 | 6 |
aGEO accession number.
bSamples treated with multiple-fraction irradiation were excluded.
cSamples from smokers were excluded.
dSamples treated with DNA minor groove binding ligand were excluded.